These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23229183)

  • 1. Which way is forward in the treatment of rectal cancer?
    Jansen RL; Beets GL
    Nat Rev Clin Oncol; 2013 Jan; 10(1):12-3. PubMed ID: 23229183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.
    Rosenthal DI; Catalano PJ; Haller DG; Landry JC; Sigurdson ER; Spitz FR; Benson AB
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):108-13. PubMed ID: 18722265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.
    Wong SJ; Moughan J; Meropol NJ; Anne PR; Kachnic LA; Rashid A; Watson JC; Mitchell EP; Pollock J; Lee RJ; Haddock M; Erickson BA; Willett CG
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):116-23. PubMed ID: 25446610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing neoadjuvant therapy for rectal cancer with oxaliplatin.
    Martin LK; Bekaii-Saab T
    J Natl Compr Canc Netw; 2013 Mar; 11(3):298-307; quiz 307. PubMed ID: 23486456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
    Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
    Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
    Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
    Landry JC; Feng Y; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Prabhu RS; Benson AB
    Cancer; 2013 Apr; 119(8):1521-7. PubMed ID: 23288663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer: initial results of the CAO/ARO/AIO-04 study].
    Reibetanz J; Germer CT
    Chirurg; 2012 Nov; 83(11):995. PubMed ID: 23089949
    [No Abstract]   [Full Text] [Related]  

  • 10. Addition of weekly oxaliplatin to standard preoperative chemoradiation for locally advanced rectal cancer.
    Aschele C; Lonardi S
    J Clin Oncol; 2007 Feb; 25(5):602-3; author reply 603. PubMed ID: 17290071
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective study.
    Wiśniowska K; Nasierowska-Guttmejer A; Polkowski W; Michalski W; Wyrwicz L; Pietrzak L; Rutkowski A; Malinowska M; Kryński J; Kosakowska E; Zwoliński J; Winiarek M; Olędzki J; Kuśnierz J; Zając L; Bednarczyk M; Szczepkowski M; Tarnowski W; Paśnik K; Radziszewski J; Partycki M; Bęczkowska K; Styliński R; Wierzbicki R; Bury P; Jankiewicz M; Paprota K; Lewicka M; Ciseł B; Skórzewska M; Mielko J; Danek A; Nawrocki G; Sopyło R; Kępka L; Bujko K;
    Eur J Surg Oncol; 2016 Dec; 42(12):1859-1865. PubMed ID: 27546011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oxaliplatin and preoperative chemoradiotherapy in rectal cancer].
    Ortholan C; Francois E; Follana P; Gérard JP
    Bull Cancer; 2006 Feb; 93 Suppl 1():S51-8. PubMed ID: 16483946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.
    Kennecke H; Berry S; Wong R; Zhou C; Tankel K; Easaw J; Rao S; Post J; Hay J
    Eur J Cancer; 2012 Jan; 48(1):37-45. PubMed ID: 21664123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
    Glynne-Jones R; Meadows H; Wood W
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiochemotherapy in rectal cancer: the role of oxaliplatin.
    Gerard JP; Glynne-Jones R; Blackstock W; Aschele C; van de Velde C
    Colorectal Dis; 2003 Nov; 5 Suppl 3():29-35. PubMed ID: 23573558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis.
    Thavaneswaran S; Kok PS; Price T
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):965-979. PubMed ID: 28819989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer.
    Barsukov YA; Gordeyev SS; Tkachev SI; Fedyanin MY; Perevoshikov AG
    Colorectal Dis; 2013 Sep; 15(9):1107-14. PubMed ID: 23668626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.
    Maréchal R; Vos B; Polus M; Delaunoit T; Peeters M; Demetter P; Hendlisz A; Demols A; Franchimont D; Verset G; Van Houtte P; Van de Stadt J; Van Laethem JL
    Ann Oncol; 2012 Jun; 23(6):1525-30. PubMed ID: 22039087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
    Calvo FA; Serrano FJ; Diaz-González JA; Gomez-Espi M; Lozano E; Garcia R; de la Mata D; Arranz JA; García-Alfonso P; Pérez-Manga G; Alvarez E
    Ann Oncol; 2006 Jul; 17(7):1103-10. PubMed ID: 16670204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results.
    Pucciarelli S; Urso E; DeSalvo GL; Aschele C; Friso ML; Rugge M; Toppan P; Bruttocao A; Fabris G; Ferraro B; Lonardi S; Frego M; Finco C; Lise M; Nitti D
    Arch Med Res; 2006 Oct; 37(7):860-5. PubMed ID: 16971226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.